151. Simulated sleep apnea alters hydrogen sulfide regulation of blood flow and pressure
- Author
-
Joshua M. Garcia, Perenkita J Mendiola, Gisel Fregoso, Laura V. Gonzalez Bosc, Nancy L. Kanagy, Humberto Morales-Loredo, Carolyn E. Pace, Jay S. Naik, and Adelaeda Barrera
- Subjects
Male ,medicine.medical_specialty ,Physiology ,Hydrogen sulfide ,Glycine ,Blood Pressure ,Hexamethonium ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,Sleep Apnea Syndromes ,Enzyme system ,Physiology (medical) ,Internal medicine ,parasitic diseases ,medicine ,Animals ,Hydrogen Sulfide ,Enzyme Inhibitors ,Mesenteric arteries ,Antihypertensive Agents ,Carotid Body ,Gasotransmitters ,Chemistry ,Cystathionine gamma-lyase ,Cystathionine gamma-Lyase ,Sleep apnea ,Intermittent hypoxia ,Blood flow ,medicine.disease ,Mesenteric Arteries ,Rats ,medicine.anatomical_structure ,Endocrinology ,Alkynes ,Blood Circulation ,Vascular Resistance ,Carotid body ,Cardiology and Cardiovascular Medicine ,Research Article - Abstract
In sleep apnea, airway obstruction causes intermittent hypoxia (IH). In animal studies, IH-dependent hypertension is associated with loss of vasodilator hydrogen sulfide (H(2)S), and increased H(2)S activation of sympathetic nervous system (SNS) activity in the carotid body. We previously reported that inhibiting cystathionine γ-lyase (CSE) to prevent H(2)S synthesis augments vascular resistance in control rats. The goal of this study was to evaluate the contribution of IH-induced changes in CSE signaling to increased blood pressure and vascular resistance. We hypothesized that chronic IH exposure eliminates CSE regulation of blood pressure (BP) and vascular resistance. In rats instrumented with venous catheters, arterial telemeters, and flow probes on the main mesenteric artery, the CSE inhibitor dl-propargylglycine (PAG, 50 mg/kg/day i.v. for 5 days) increased BP in Sham rats but decreased BP in IH rats [in mmHg, Sham (n = 11): 114 ± 4 to 131 ± 6; IH (n = 8): 131 ± 8 to 115 ± 7 mmHg, P < 0.05]. PAG treatment increased mesenteric vascular resistance in Sham rats but decreased it in IH rats (day 5/day 1: Sham: 1.50 ± 0.07; IH: 0.85 ± 0.19, P < 0.05). Administration of the ganglionic blocker hexamethonium (to evaluate SNS activity) decreased mesenteric resistance in PAG-treated Sham rats more than in saline-treated Sham rats or PAG-treated IH rats. CSE immunoreactivity in IH carotid bodies compared with those from Sham rats. However, CSE staining in small mesenteric arteries was less in arteries from IH than in Sham rats but not different in larger arteries (inner diameter > 200 µm). These results suggest endogenous H(2)S regulates blood pressure and vascular resistance, but this control is lost after IH exposure with decreased CSE expression in resistance size arteries. IH exposure concurrently increases carotid body CSE expression and relative SNS control of blood pressure, suggesting both vascular and carotid body H(2)S generation contribute to blood pressure regulation. NEW & NOTEWORTHY These results suggest that CSE’s protective role in the vasculature is impaired by simulated sleep apnea, which also upregulates CSE in the carotid body. Thus, this enzyme system can exert both pro- and antihypertensive effects and may contribute to elevated SNS outflow in sleep apnea.
- Published
- 2021